View in EDS PDF Full Text

Loss of SLC25A20 in Pancreatic Adenocarcinoma Reversed the Tumor-Promoting Effects of a High-Fat Diet.

Saved in:
Bibliographic Details
Title: Loss of SLC25A20 in Pancreatic Adenocarcinoma Reversed the Tumor-Promoting Effects of a High-Fat Diet.
Authors: Woo SM; Research Institute, National Cancer Center, Goyang, Republic of Korea.; Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Republic of Korea.; Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang, Republic of Korea., Lee H; Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Republic of Korea.; Cancer Molecular Biology Branch, Research Institute, National Cancer Center, Goyang, Republic of Korea., Kang JH; Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Republic of Korea.; New Cancer Cure-Bio Co., Goyang, Republic of Korea., Kang M; Cancer Molecular Biology Branch, Research Institute, National Cancer Center, Goyang, Republic of Korea.; New Cancer Cure-Bio Co., Goyang, Republic of Korea., Choi W; Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Republic of Korea.; Cancer Molecular Biology Branch, Research Institute, National Cancer Center, Goyang, Republic of Korea.; Therapeutic Resistance Research Branch, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea., Sim SH; Therapeutic Resistance Research Branch, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea., Chun JW; Research Institute, National Cancer Center, Goyang, Republic of Korea.; Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Republic of Korea.; Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang, Republic of Korea., Han N; Department of Pathology, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea., Kim KH; Proteomics Core Facility, Research Core Center, Research Institute, National Cancer Center, Goyang, Republic of Korea., Ham W; Cancer Molecular Biology Branch, Research Institute, National Cancer Center, Goyang, Republic of Korea.; New Cancer Cure-Bio Co., Goyang, Republic of Korea., Hong W; Cancer Molecular Biology Branch, Research Institute, National Cancer Center, Goyang, Republic of Korea.; New Cancer Cure-Bio Co., Goyang, Republic of Korea., Kim C; Cancer Molecular Biology Branch, Research Institute, National Cancer Center, Goyang, Republic of Korea.; New Cancer Cure-Bio Co., Goyang, Republic of Korea., Park JH; Cancer Molecular Biology Branch, Research Institute, National Cancer Center, Goyang, Republic of Korea., Han D; Department of Oral Pathology, Yonsei University College of Dentistry, Seoul, Korea., Yook JI; Department of Oral Pathology, Yonsei University College of Dentistry, Seoul, Korea., Lee WJ; Research Institute, National Cancer Center, Goyang, Republic of Korea.; Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang, Republic of Korea., Kim SY; Cancer Molecular Biology Branch, Research Institute, National Cancer Center, Goyang, Republic of Korea.; New Cancer Cure-Bio Co., Goyang, Republic of Korea.
Source: Theranostics [Theranostics] 2025 May 25; Vol. 15 (13), pp. 6516-6533. Date of Electronic Publication: 2025 May 25 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1838-7640
DOI:10.7150/thno.114912